Physician profile

Ennis Zaitoon

Internal Medicine · Corona, CA

NPI 1235307141

$6,676.39

in general payments reported to CMS, 2019-2025

29 companies · $4,932 in 2025

The $4,932 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,550.00
Food and Beverage$885.15
Travel and Lodging$13.30

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $4,938.01 2019-2025 Zepbound, Mounjaro
Novo Nordisk INC $573.57 2019-2025 Ozempic, Rybelsus, Wegovy
Amgen INC. $264.34 2019-2023 Repatha, Otezla
Boehringer Ingelheim Pharmaceuticals, INC. $95.40 2019
Sunovion Pharmaceuticals INC. $76.50 2019
Eisai INC. $75.98 2019
Glaxosmithkline, LLC. $68.28 2022-2023 Arexvy, Shingrix
Pfizer INC. $57.73 2019
Bayer Healthcare Pharmaceuticals INC. $49.36 2024
Astellas Pharma US INC $45.12 2023-2024 Veozah
Astrazeneca Pharmaceuticals LP $42.48 2019
Sanofi-Aventis U.S. LLC $41.22 2019-2020
Hologic Sales and Service, LLC $39.07 2022-2024 Thinprep 2000 Processor
Nalpropion Pharmaceuticals LLC $38.70 2019
Exact Sciences Corporation $37.63 2024-2025 Cologuard Collection Kit
Show all 29 companies
CompanyGeneral paymentsYearsTop products
Abbott Laboratories $25.82 2022
Edwards Lifesciences Corporation $22.89 2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Urovant Sciences INC $19.03 2022
Sumitomo Pharma America, INC. $18.49 2024 Gemtesa
Teva Pharmaceuticals USA, INC. $18.48 2019
Janssen Biotech, INC. $16.96 2019
Redhill Biopharma INC. $16.23 2023 Talicia
Hikma Pharmaceuticals USA $14.88 2019
Intra-Sana Laboratories $14.76 2024 Reltone 400 Mg, Glycate, Reltone 200 Mg
Janssen Pharmaceuticals, INC $14.62 2019
Currax Pharmaceuticals LLC $14.31 2019
Amarin Pharma, INC. $12.93 2019
E.R. Squibb & Sons, L.L.C. $12.73 2019
Merck Sharp & Dohme LLC $10.87 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ennis Zaitoon

$6,676.39

in general payments reported 2019-2025

Years
2019-2025
Top company
Lilly USA, LLC
Context
The $4,932 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/56268/ennis-zaitoon

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.